US Patent Issued to Icahn School of Medicine at Mount Sinai on July 14 for "Protein tyrosine kinase 6 (PTK6) degradation / disruption compounds and methods of use" (New York Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,678,507, issued on July 14, was assigned to Icahn School of Medicine at Mount Sinai (New York).

"Protein tyrosine kinase 6 (PTK6) degradation / disruption compounds and methods of use" was invented by Jian Jin (New York), Hanna Irie (New York), Jing Liu (New York), Yan Xiong (New York), Jessica Byerly (New York), Shannon Tomita (New York) and Jianping Hu (New York).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are protein tyrosine kinase 6 (PTK6) degradation/disruption compounds including a PTK6 ligand, a degradation/disruption tag, and a linker, and methods of using such compounds in the treatment of FTK6-mediated diseases."

The paten...